Shantell Laketa Heiber

Array ( [id] => 7142705 [patent_doc_number] => 20050118139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Vaccine using papilloma virus e proteins delivered by viral vector' [patent_app_type] => utility [patent_app_number] => 10/487148 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7489 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118139.pdf [firstpage_image] =>[orig_patent_app_number] => 10487148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 452671 [patent_doc_number] => 07247433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles' [patent_app_type] => utility [patent_app_number] => 10/486564 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9291 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247433.pdf [firstpage_image] =>[orig_patent_app_number] => 10486564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821287 [patent_doc_number] => 20030219448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases' [patent_app_type] => new [patent_app_number] => 10/213053 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7841 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219448.pdf [firstpage_image] =>[orig_patent_app_number] => 10213053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1100907 [patent_doc_number] => 06814969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'Immunologically significant herpes simplex virus antigens and methods for using same' [patent_app_type] => B2 [patent_app_number] => 10/210428 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 23653 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/814/06814969.pdf [firstpage_image] =>[orig_patent_app_number] => 10210428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711530 [patent_doc_number] => 20030171279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Methods and composition concerning herpesvirus Us3 and BAD-involved apoptosis' [patent_app_type] => new [patent_app_number] => 10/209967 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 51129 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171279.pdf [firstpage_image] =>[orig_patent_app_number] => 10209967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061692 [patent_doc_number] => 20050004054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/485454 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3193 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004054.pdf [firstpage_image] =>[orig_patent_app_number] => 10485454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104478 [patent_doc_number] => 06811983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-02 [patent_title] => 'Method of identifying inhibitors of EBNA-1' [patent_app_type] => B2 [patent_app_number] => 10/201887 [patent_app_country] => US [patent_app_date] => 2002-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8781 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/811/06811983.pdf [firstpage_image] =>[orig_patent_app_number] => 10201887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528825 [patent_doc_number] => 20020192802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Replication competent herpes virus strains' [patent_app_type] => new [patent_app_number] => 10/181698 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6334 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192802.pdf [firstpage_image] =>[orig_patent_app_number] => 10181698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846652 [patent_doc_number] => 20030165819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Compositions and methods for the diagnosis and treatment of herpes simplex virus infection' [patent_app_type] => new [patent_app_number] => 10/200562 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50041 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165819.pdf [firstpage_image] =>[orig_patent_app_number] => 10200562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 816950 [patent_doc_number] => 07410758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN' [patent_app_type] => utility [patent_app_number] => 10/484063 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37623 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410758.pdf [firstpage_image] =>[orig_patent_app_number] => 10484063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275498 [patent_doc_number] => 20040234949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Icosahedral superstructures of vp2 of infectious bursitis virus (ibdv) and the applications thereof' [patent_app_type] => new [patent_app_number] => 10/483110 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9479 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234949.pdf [firstpage_image] =>[orig_patent_app_number] => 10483110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046921 [patent_doc_number] => 20020168385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Adeno-associated virus vector for boosting immunogenicity of cells' [patent_app_type] => new [patent_app_number] => 10/188994 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2852 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168385.pdf [firstpage_image] =>[orig_patent_app_number] => 10188994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1272269 [patent_doc_number] => 06649169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-18 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => B2 [patent_app_number] => 10/180633 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15452 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649169.pdf [firstpage_image] =>[orig_patent_app_number] => 10180633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651058 [patent_doc_number] => 20030105008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses' [patent_app_type] => new [patent_app_number] => 10/178055 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21979 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105008.pdf [firstpage_image] =>[orig_patent_app_number] => 10178055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247551 [patent_doc_number] => 06673354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Compositions and methods for treating papillomavirus-infected cells' [patent_app_type] => B2 [patent_app_number] => 10/161499 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 30186 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673354.pdf [firstpage_image] =>[orig_patent_app_number] => 10161499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801139 [patent_doc_number] => 20030096304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Nuclear matrix protein fluid assay' [patent_app_type] => new [patent_app_number] => 10/151717 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9431 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096304.pdf [firstpage_image] =>[orig_patent_app_number] => 10151717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696376 [patent_doc_number] => 20030108570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis' [patent_app_type] => new [patent_app_number] => 10/147951 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6027 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108570.pdf [firstpage_image] =>[orig_patent_app_number] => 10147951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432041 [patent_doc_number] => 07264814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Composition and method for treating cancer using herpes virus' [patent_app_type] => utility [patent_app_number] => 10/477444 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23157 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264814.pdf [firstpage_image] =>[orig_patent_app_number] => 10477444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264153 [patent_doc_number] => 06660513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-09 [patent_title] => 'Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142' [patent_app_type] => B2 [patent_app_number] => 10/143186 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16692 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660513.pdf [firstpage_image] =>[orig_patent_app_number] => 10143186 [rel_patent_id] =>[rel_patent_doc_number] =>)